About MedReg Intel

MedReg Intel publishes The India Device Forecast — a regulatory intelligence practice tracking which medical devices will enter India before they file with CDSCO.

My edge comes from seven years inside government health procurement (NHM/CGMSC), where I saw which approved devices actually reached hospitals — and which did not.

This blog publishes weekly intelligence signals: FDA clearances with India relevance, CDSCO enforcement shifts, and state tender anomalies. The full FDA→CDSCO pipeline analysis, prediction vault, and running accuracy scorecard live in the monthly newsletter.

I focus exclusively on pre-filing intelligence and market entry forecasting — for PE funds, MNCs, and distributors who need to know which devices will clear — and which will fail — before the market does.

About the Author

Ankur Khare 

Regulatory Intelligence Analyst | Founder, MedReg Intel | Publisher of The India Device Forecast

Disclaimer

MedReg Intel is an independent regulatory intelligence platform and is not affiliated with CDSCO, the Government of India, or any regulatory authority. The information provided is for educational and informational purposes only and should not be interpreted as official regulatory advice.

Comments

Post a Comment

Popular posts from this blog

The ₹50 Lakh Mistake Killing Indian MedTech Startups — And How to Avoid It

The One Regulatory Mistake That Costs Indian MedTech Startups ₹50 Lakh and 2 Years — And How to Avoid It By Ankur Khare — Biomedical Engineer | Regulatory Affairs Specialist | Founder- MedReg Intel There is a mistake so common in Indian MedTech startups that I have started calling it the Silent Killer of early stage medical device companies. It does not show up in your pitch deck. Your investors will not catch it. Your product team will not flag it. Even your legal counsel may miss it — unless they have specific medical device regulatory experience. By the time most startups discover this mistake, they have already spent ₹30 to ₹50 lakh in product development, hired a team, signed letters of intent with hospital procurement departments, and told their investors they are six months from launch. Then CDSCO sends a deficiency notice. Or worse — a rejection. And suddenly those six months become two years. This article is about that mistake. What it is, why it keeps happening, what ...
Read more

Make in India for Medical Devices — The Reality No One Is Talking About

Make in India for Medical Devices — The Honest Truth About What Is Working, What Is Not, and What It Will Take to Build a World-Class MedTech Industry By Ankur Khare — Biomedical Engineer | Regulatory Affairs Specialist | Founder, MedReg Intel India imports approximately 70 to 80 percent of its medical devices. Read that again. The world's most populous country — a nation with one of the fastest-growing economies on earth, a massive domestic healthcare need, and a government that has made manufacturing self-sufficiency a centrepiece of national policy — still depends on foreign manufacturers for most of the devices used in its hospitals every single day. The Make in India initiative for medical devices has been running for nearly a decade. The Production Linked Incentive scheme has committed thousands of crores in government support. CDSCO has been strengthened and modernised. Medical device parks have been established. And yet the import dependence persists. This is not a s...
Read more

A Practical Roadmap for Developing Medical Devices in India

A Practical Roadmap for Developing Medical Devices in India From Idea to Market — Without Costly Regulatory Mistakes By Ankur K. Khare – Biomedical Engineer | Regulatory Affairs Specialist | AI Ethics & Medical Innovation Developing a medical device in India is not just an engineering challenge. It is a regulatory, clinical, manufacturing, and ethical journey — and most failures happen not because the product is bad, but because the roadmap is wrong . Too many teams build first and think about regulation later. By the time CDSCO enters the picture, timelines are already broken. This guide lays out a clear, India-specific roadmap for medical device development — grounded in MDR 2017, CDSCO scrutiny patterns, and real-world failures — so teams can build right , not just fast. Why This Matters An incorrect development sequence can: Delay approvals by months Multiply compliance costs Force redesigns late in the lifecycle Undermine regulatory credibility Most of this is preventable —...
Read more